| AHI | Apnea–Hypopnea Index |
| CRSwNP | Chronic Rhinosinusitis with Nasal Polyps |
| CRSsNP | Chronic Rhinosinusitis without Nasal Polyps |
| EPOS | European Position Paper on Rhinosinusitis |
| ESS | Epworth Sleepiness Scale |
| EUFOREA | European Forum for Research and Education in Allergy and Airways diseases |
| FDA | US Food and Drug Administration |
| FeNO | Fractional Exhaled Nitric Oxide |
| HRQoL | Health-Related Quality of Life |
| IgE | Immunoglobulin E |
| IL-4 | Interleukin-4 |
| IL-4Rα | Interleukin-4 receptor alpha |
| IL-5 | Interleukin-5 |
| IL-10 | Interleukin-10 |
| IL-13 | Interleukin-13 |
| INCS | Intranasal Corticosteroids |
| ISI | Insomnia Severity Index |
| MCID | Minimal Clinically Important Difference |
| MeSH | Medical Subject Headings |
| NOSE | Nasal Obstruction Symptom Evaluation |
| NPS | Nasal Polyp Score |
| NREM | Non-Rapid Eye Movement |
| OSA | Obstructive Sleep Apnea |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PROMs | Patient-Reported Outcome Measures |
| PSQI | Pittsburgh Sleep Quality Index |
| QoL | Quality of Life |
| REM | Rapid Eye Movement |
| ROBINS-I | Risk of Bias in Non-randomized Studies of Interventions |
| RoB 2 | Cochrane Risk of Bias tool for randomized trials |
| SDB | Sleep-Disordered Breathing |
| SNOT-22 | Sinonasal Outcome Test-22 |
| TNF | Tumor Necrosis Factor |
| TGF-β | Transforming Growth Factor beta |
| VAS | Visual Analogue Scale |